Copy of Newspaper Publication

Medplus Health Services Limited November 10, 2026 Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (E), Mumbai 400 051 BSE Scrip code: 543427 NSE Symbol: MEDPLUS Subject: Submission of Board Resolution and Public Announcement for Buyback of equity shares of MedPlus Health Services Limited (the “Company”) through open market route. Ref: Regulation 7(i) and (ii) and Regulation 16(iv) of Securities and Exchange Board of India (Buy- Back of Securities) Regulations, 2018 . Dear Sir/ Ma’am, This is in furtherance to our intimation dated November 06, 2026 informing the stock exchanges, that the Board of Directors of the Company has approved the proposal for buyback of fully paid up equity shares of the Company having a face value of ₹2/- (Indian Rupees Two only) each (“Equity Shares” and such buyback “Buyback”), from all shareholders/ beneficial owners of the Equity Shares of the Company (other than the promoters and persons in control of the Company), through the “open market” route, using mechanism for acquisition of shares through stock exchange at a price not exceeding ₹750/- (Indian Rupees Seven Hundred and Fifty only) per Equity Share (“Maximum Buyback Price”), payable in cash, for an aggregate amount not exceeding ₹ 130.00 Crores/- (Indian Rupees One Hundred and Thirty Crores only) (“Maximum Buyback Size”) excluding Transaction costs, in accordance with the provisions of the Companies Act, 2013, and rules made thereunder, and the Securities and Exchange Board of India (Buy- Back of Securities) Regulations, 2018 (the “SEBI Buyback Regulations”) as amended from time to time and other applicable laws. In this connection, we wish to inform you that the Company has made a Public Announcement dated November 09, 2026 (“Public Announcement”) for the Buyback in the newspapers mentioned below: Name of the Newspaper Language Editions Financial Express English All editions* Jansatta Hindi All editions* Nava Telangana Telugu Hyderabad^ *Except Lucknow edition of Financial Express & Jansatta, which will be published on 11th November, 2026 ^Telugu being the regional language of Telangana, where the Registered Office of the Company is situated In this regard, please find the following as enclosures: (a) Certified true copy of the resolution passed by the Board of Directors dated November 06, 2026 for approving the proposal of Buyback (Annexure I); and (b) Copy of the Public Announcement, as published in the aforesaid newspapers (Annexure II) Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com | Ph.: 040-67246724 Medplus Health Services Limited Further, the Buyback of equity shares of the company as mentioned in the outcome of Board Meeting and the Public Announcement shall open on Friday, November 13, 2026. Furthermore, as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and the SEBI Buyback Regulations, the copy of the Public Announcement would also be available on the website of the Company, i.e. www.medplusindia.com, Nuvama Wealth Management Limited (the manager to the Buyback), i.e. www.nuvama.com, BSE Limited, i.e. www.bseindia.com and National Stock Exchange of India Limited i.e. www.nseindia.com. Kindly take the same on record. Thanking You, Yours faithfully For Medplus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer ICSI M. No.: F12400 Encl.: as above Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com | Ph.: 040-67246724 Annexure I MedPlus::: MedPlus Health Services Limited CERTIFIED TRUE COPY OF THE RESOLUTION PASSED IN THE MEETING 06/2026-27 BY THE BOARD OF DIRECTORS OF MEDPLUS HEALTH SERVICES LIMITED HELD ON FRIDAY, NOVEMBER 06, 2026, AT 10:30 A.M. AT THE REGISTERED OFFICE OF THE COMPANY AT H. NO: 11-6-56, SURVEY NO. 257 & 258/1, OPP: IDPL RAILWAY SIDING ROAD, (MOOSAPET), KUKATPALLY, HYDERABAD — 500037, TELANGANA. CONSIDER AND APPROVE THE PROPOSAL FOR BUY-BACK OF FULLY PAID-UP EQUITY SHARES OF THE COMPANY THROUGH THE OPEN MARKET USING THE STOCK EXCHANGE MECHANISM AND MATTERS INCIDENTAL AND ANCILLARY THERETO. "RESOLVED THAT pursuant to the provisions of Article 77 of the Articles of Association of the Company and the provisions of Sections 68, 69, 70 and all other applicable provisions, if any, of the Companies Act, 2013, as amended (the "Companies Act") read with the Companies (Share Capital and Debentures) Rules, 2014 (to the extent applicable) (hereinafter referred to as the "Share Capital Rules"), and other applicable rules made thereunder, each as amended from time to time and the provisions of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended ("SEBI iLlyback Regulations"), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) "gulations, 2015, as amended ("SEBI Listing Regulations") and such other applicable circulars, guidelines and directions issued by the Securities and Exchange Board of India ("SEBI"), (including any statutory modifications, amendments, re- enactment thereof) and subject to such other approvals, permissions, consents, sanctions and exemptions as may be necessary and subject to any modifications and conditions, if any, as may be prescribed by the SEBI, Registrar of Companies, Telangana at Hyderabad (the "RoC"), BSE Limited ("BSE"), National Stock Exchange of India Limited ("NSE") and/or other authorities, institutions or bodies (together with SEBI, BSE and NSE, the "Appropriate Authorities"), as may be necessary, and subject to such conditions, alterations, amendments and modifications as may be prescribed or imposed by them while granting such approvals, permissions, consents, sanctions and exemptions which may be agreed by the Board of Directors of the Company ("Board", which term shall be deemed to include any committee of the Board and/or officials, which the Board may constitute/authorise to exercise its powers, including the powers conferred by this resolution ("Buyback Committee")), be and is hereby consents and approves the buyback by the Company of its fully paid-up equity shares having a face value of (cid:9) each (Indian Rupees Two only) ("Equity Shares") from its shareholders/beneficial owners (other than those who are promoters and persons in control of the Company) in cash from the open market through stock exchanges (having nationwide trading terminals) for an aggregate amount not exceeding 130,00,00,000/- (Indian Rupees One Hundred Thirty Crores only) ("Maximum Buyback Size") representing an aggregate of 9.87% and 6.61% of the Company's fully paid-up Equity Share capital and free reserves based on both the audited standalone and consolidated financial statements of the Company as at March 31, 2026, respectively (being the latest available audited standalone and consolidated financial statements of the Company), which is within the statutory limits of 10% of the total paid-up Equity Share capital and free reserves based on both standalone and consolidated financial statements of the Company as at March 31, 2026, at a price not exceeding 750/- (Indian Rupees Seven Hundred Fifty only) per Equity Share ("Maximum n4yback Price") (such process is hereinafter referred to as the "Buyback"). The Maximum Buyback Size does not include ransaction costs incurred or to be incurred for the Buyback viz, brokerage, turnover charges, applicable taxes such as securities transaction tax, goods and service tax, stamp duty, expenses incurred for the Buyback like filin [Showing first 8,000 characters — download PDF for full document]